Emergent BioSolutions EVP, Chief Growth Officer Stephanie Duatschek files initial beneficial ownership statement
EBS•Initial Form 3 filing reported
Emergent BioSolutions EVP, chief growth officer Stephanie Duatschek reported 197,416 common shares in an initial Form 3 filing.
